Cancers after cyclosporine therapy.
Penn
I
I
University of Cincinnati Medical Center, OH 45267.
D001005:Anus Neoplasms / Q000453:epidemiology / Q000209:etiology; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004198:Disease Susceptibility; D005260:Female; D005833:Genital Neoplasms, Female / Q000453:epidemiology / Q000209:etiology; D006084:Graft Rejection; D006258:Head and Neck Neoplasms / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D007680:Kidney Neoplasms / Q000453:epidemiology / Q000209:etiology; D008223:Lymphoma / Q000453:epidemiology / Q000209:etiology; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D011183:Postoperative Complications / Q000209:etiology* / Q000276:immunology; D012514:Sarcoma, Kaposi / Q000453:epidemiology / Q000209:etiology; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology; D014180:Transplantation
D003524:Cyclosporins